BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34581708)

  • 1. Computed Tomography Imaging Characteristics: Potential Indicators of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma.
    Wang B; Yu N; Han D; Ren Z; Jia Y; Zhang X; He T
    J Comput Assist Tomogr; 2021 Nov-Dec 01; 45(6):964-969. PubMed ID: 34581708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of EGFR mutations by conventional CT-features in advanced pulmonary adenocarcinoma.
    Chen Y; Yang Y; Ma L; Zhu H; Feng T; Jiang S; Wei Y; Wang T; Sun X
    Eur J Radiol; 2019 Mar; 112():44-51. PubMed ID: 30777218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CT Features Associated with Epidermal Growth Factor Receptor Mutation Status in Patients with Lung Adenocarcinoma.
    Liu Y; Kim J; Qu F; Liu S; Wang H; Balagurunathan Y; Ye Z; Gillies RJ
    Radiology; 2016 Jul; 280(1):271-80. PubMed ID: 26937803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging-Based Surrogate Markers of Epidermal Growth Factor Receptor Mutation in Lung Adenocarcinoma: A Local Perspective.
    AlGharras A; Kovacina B; Tian Z; Alexander JW; Semionov A; van Kempen LC; Sayegh K
    Can Assoc Radiol J; 2020 May; 71(2):208-216. PubMed ID: 32062999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of epidermal growth factor receptor mutations in pulmonary adenocarcinoma using dual-energy spectral computed tomography.
    Li M; Zhang L; Tang W; Jin YJ; Qi LL; Wu N
    Eur Radiol; 2019 Jun; 29(6):2989-2997. PubMed ID: 30367185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between epidermal growth factor receptor mutations and CT features in patients with lung adenocarcinoma.
    Zhang G; Zhao Z; Cao Y; Zhang J; Li S; Deng L; Zhou J
    Clin Radiol; 2021 Jun; 76(6):473.e17-473.e24. PubMed ID: 33731263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT features associated with EGFR mutations and ALK positivity in patients with multiple primary lung adenocarcinomas.
    Han X; Fan J; Gu J; Li Y; Yang M; Liu T; Li N; Zeng W; Shi H
    Cancer Imaging; 2020 Jul; 20(1):51. PubMed ID: 32690092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between EGFR mutation status and computed tomography features in patients with advanced pulmonary adenocarcinoma.
    Hsu JS; Huang MS; Chen CY; Liu GC; Liu TC; Chong IW; Chou SH; Yang CJ
    J Thorac Imaging; 2014 Nov; 29(6):357-63. PubMed ID: 25303964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of ¹⁸F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma.
    Ko KH; Hsu HH; Huang TW; Gao HW; Shen DH; Chang WC; Hsu YC; Chang TH; Chu CM; Ho CL; Chang H
    Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1889-97. PubMed ID: 24852187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CT imaging-based histogram features for prediction of EGFR mutation status of bone metastases in patients with primary lung adenocarcinoma.
    Shen TX; Liu L; Li WH; Fu P; Xu K; Jiang YQ; Pan F; Guo Y; Zhang MC
    Cancer Imaging; 2019 Jun; 19(1):34. PubMed ID: 31174617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Computed Tomography-Based Radiomics Signature: A Potential Indicator of Epidermal Growth Factor Receptor Mutation in Pulmonary Adenocarcinoma Appearing as a Subsolid Nodule.
    Yang X; Dong X; Wang J; Li W; Gu Z; Gao D; Zhong N; Guan Y
    Oncologist; 2019 Nov; 24(11):e1156-e1164. PubMed ID: 30936378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of CT features and quantitative texture analysis in patients with lung adenocarcinoma: a correlation with EGFR mutations and survival rates.
    Sacconi B; Anzidei M; Leonardi A; Boni F; Saba L; Scipione R; Anile M; Rengo M; Longo F; Bezzi M; Venuta F; Napoli A; Laghi A; Catalano C
    Clin Radiol; 2017 Jun; 72(6):443-450. PubMed ID: 28258739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between clinical data and computed tomography features in patients with epidermal growth factor receptor mutations in lung adenocarcinoma.
    Cao Y; Xu H; Liao M; Qu Y; Xu L; Zhu D; Wang B; Tian S
    Int J Clin Oncol; 2018 Apr; 23(2):249-257. PubMed ID: 28988295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel radiomic nomogram for predicting epidermal growth factor receptor mutation in peripheral lung adenocarcinoma.
    Lu X; Li M; Zhang H; Hua S; Meng F; Yang H; Li X; Cao D
    Phys Med Biol; 2020 Mar; 65(5):055012. PubMed ID: 31978901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying EGFR mutations in lung adenocarcinoma by noninvasive imaging using radiomics features and random forest modeling.
    Jia TY; Xiong JF; Li XY; Yu W; Xu ZY; Cai XW; Ma JC; Ren YC; Larsson R; Zhang J; Zhao J; Fu XL
    Eur Radiol; 2019 Sep; 29(9):4742-4750. PubMed ID: 30778717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II lung adenocarcinoma.
    Zou J; Lv T; Zhu S; Lu Z; Shen Q; Xia L; Wu J; Song Y; Liu H
    Thorac Cancer; 2017 May; 8(3):260-270. PubMed ID: 28383802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma.
    Han X; Fan J; Li Y; Cao Y; Gu J; Jia X; Wang Y; Shi H
    Sci Rep; 2021 Mar; 11(1):5679. PubMed ID: 33707479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual-energy spectral CT characteristics in surgically resected lung adenocarcinoma: comparison between Kirsten rat sarcoma viral oncogene mutations and epidermal growth factor receptor mutations.
    Li M; Zhang L; Tang W; Duan JC; Jin YJ; Qi LL; Wu N
    Cancer Imaging; 2019 Nov; 19(1):77. PubMed ID: 31783917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Relationship between EGFR, ALK Gene Mutation and Imaging 
and Pathological Features in Invasive Lung Adenocarcinoma].
    Yang H; Liu Z; Wang H; Chen L; Wang J; Wen W; Xu X; Zhu Q
    Zhongguo Fei Ai Za Zhi; 2022 Mar; 25(3):147-155. PubMed ID: 35340157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic phenotype of stage IV lung adenocarcinoma: relationship with epidermal growth factor receptor mutation.
    Lee EY; Khong PL; Lee VH; Qian W; Yu X; Wong MP
    Clin Nucl Med; 2015 Mar; 40(3):e190-5. PubMed ID: 25608155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.